Weaver A M, Lysiak J J, Gonias S L
Department of Pathology, University of Virginia Health Sciences Center, Charlottesville 22908, USA.
J Lipid Res. 1997 Sep;38(9):1841-50.
Lipoprotein lipase (LPL) promotes the binding and internalization of beta-VLDL (very low density lipoprotein) by many cell types. We examined the function of receptors in the LDL receptor family (LRF) and heparan sulfate proteoglycans (HSPG) in the metabolism of LPL-associated beta-VLDLa by rat vascular smooth muscle cells (VSMCs) in culture. These cells express LDL receptor-related protein and the VLDL receptor, but not the LDL receptor. LPL greatly increased the binding of 125I-labeled beta-VLDL to VSMCs at 4 degrees C. Binding was almost entirely inhibited by heparin, but essentially unaffected by the potent LRF-antagonist, receptor-associated protein (RAP), indicating that LRFs do not contribute significantly to the VSMC binding capacity for LPL-associated beta-VLDL. At 37 degrees C, RAP inhibited the rapid internalization of LPL-associated 125I-labeled beta-VLDL and the digestion of the beta-VLDL into trichloroacetic acid soluble radioactivity; these processes still occurred, but at a decreased rate. RAP did not inhibit the ability of beta-VLDL-LPL complex to stimulate VSMC ACAT activity. Furthermore, in Oil red-O histochemistry experiments, which model foam cell transformation in vitro, RAP paradoxically increased cholesteryl ester storage in VSMCs treated with beta-VLDL and LPL under specific cell culture conditions. These results support a model in which the internalization of LPL-associated beta-VLDL by VSMCs is mediated by two pathways, one involving LRFs and a second that is independent of LRFs, probably involving direct uptake by HSPG. The LRF-dependent pathway leads to less cellular storage of cholesteryl ester and thus may be antiatherogenic under certain conditions.
脂蛋白脂肪酶(LPL)可促进多种细胞类型对β-VLDL(极低密度脂蛋白)的结合与内化。我们研究了低密度脂蛋白受体家族(LRF)中的受体以及硫酸乙酰肝素蛋白聚糖(HSPG)在培养的大鼠血管平滑肌细胞(VSMC)对LPL相关β-VLDLa代谢中的作用。这些细胞表达低密度脂蛋白受体相关蛋白和VLDL受体,但不表达低密度脂蛋白受体。在4℃时,LPL显著增加了125I标记的β-VLDL与VSMC的结合。肝素几乎完全抑制了这种结合,但强效LRF拮抗剂受体相关蛋白(RAP)对其基本没有影响,这表明LRF对VSMC结合LPL相关β-VLDL的能力贡献不大。在37℃时,RAP抑制了LPL相关的125I标记β-VLDL的快速内化以及β-VLDL被消化为三氯乙酸可溶性放射性物质的过程;这些过程仍会发生,但速率降低。RAP并不抑制β-VLDL-LPL复合物刺激VSMC ACAT活性的能力。此外,在模拟体外泡沫细胞转化的油红O组织化学实验中,在特定细胞培养条件下,RAP反常地增加了用β-VLDL和LPL处理的VSMC中胆固醇酯的储存。这些结果支持了一个模型,即VSMC对LPL相关β-VLDL的内化由两条途径介导,一条涉及LRF,另一条独立于LRF,可能涉及HSPG的直接摄取。依赖LRF的途径导致细胞内胆固醇酯储存减少,因此在某些条件下可能具有抗动脉粥样硬化作用。